Literature DB >> 1350815

Lamotrigine.

M J Brodie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350815     DOI: 10.1016/0140-6736(92)91207-o

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  35 in total

1.  Psychotic disorder after lamotrigine.

Authors:  G M Polselli; E M Pennisi; L Figà Talamanca; R Roberti; F F Garelli; P L Bandinelli
Journal:  Ital J Neurol Sci       Date:  1998-04

Review 2.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 3.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

4.  Hypersensitivity to topiramate sprinkle capsules does not preclude the use of topiramate tablets.

Authors:  Dorothy Marsden; Susan E Libretto
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 5.  Management of focal-onset seizures: an update on drug treatment.

Authors:  Svein I Johannessen; Elinor Ben-Menachem
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  Newer anti-epileptic drugs.

Authors:  S Aneja; R W Newton
Journal:  Indian J Pediatr       Date:  1996 Mar-Apr       Impact factor: 1.967

7.  Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service.

Authors:  R G Morris; A B Black; A L Harris; A B Batty; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 8.  Antiepileptic drugs and mechanisms of epileptogenesis. A review.

Authors:  R Mutani; R Cantello; M Gianelli; C Civardi
Journal:  Ital J Neurol Sci       Date:  1995-05

Review 9.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 10.  Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.

Authors:  K L Goa; S R Ross; P Chrisp
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.